Galectin Therapeutics News

Galectin Therapeutics | 8-K: Current report

Nov 14 21:06

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

Nov 14 21:01

Galectin Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14 20:56

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELDRED KARY

Oct 24 01:45

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

Oct 18 04:08

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

Oct 17 04:13

Galectin Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 5 04:14

Galectin Therapeutics | 8-K: Current report

Sep 9 20:05

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.

Aug 26 20:11

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update

Aug 13 19:57

Galectin Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 13 19:52

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jamil Khurram

Aug 5 20:42

Galectin Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Jamil Khurram

Aug 5 20:42

Galectin Therapeutics | 8-K: Current report

Aug 1 19:56

Galectin Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director ELDRED KARY

Jul 23 21:44

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELDRED KARY

Jul 23 21:39

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

Jun 21 01:56

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update

May 15 20:00

Galectin Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15 19:55

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.

May 1 02:16